US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 0.9283
  • -0.0127-1.35%
Close Dec 20 16:00 ET
  • 0.9865
  • +0.0582+6.27%
Post 17:42 ET
171.23MMarket Cap-1.11P/E (TTM)

Nektar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-0.08%24.12M
14.59%23.49M
0.21%21.64M
-2.10%90.12M
8.45%23.89M
2.20%24.14M
-5.03%20.5M
-13.00%21.59M
-9.67%92.06M
-11.94%22.02M
Operating revenue
-0.08%24.12M
14.59%23.49M
0.21%21.64M
-2.10%90.12M
8.45%23.89M
2.20%24.14M
-5.03%20.5M
-13.00%21.59M
-9.67%92.06M
-11.94%22.02M
Cost of revenue
-64.32%4.44M
39.26%9.74M
20.88%8.53M
56.08%33.77M
16.85%7.28M
150.02%12.43M
36.74%6.99M
32.83%7.06M
-13.10%21.64M
1.14%6.23M
Gross profit
68.10%19.69M
1.81%13.75M
-9.83%13.11M
-19.97%56.35M
5.14%16.6M
-37.21%11.71M
-18.00%13.51M
-25.49%14.53M
-8.56%70.42M
-16.22%15.79M
Operating expense
19.40%53.99M
5.64%50.23M
-7.75%47.56M
-38.33%191.58M
-16.61%47.26M
-19.43%45.22M
-24.84%47.55M
-61.70%51.55M
-40.61%310.66M
-56.98%56.68M
Selling and administrative expenses
-10.36%18.96M
14.78%20.51M
-4.42%20.15M
-16.15%77.42M
-21.05%17.32M
-6.16%21.15M
-12.92%17.87M
-22.89%21.08M
-24.84%92.33M
-31.74%21.94M
-General and administrative expense
-10.36%18.96M
14.78%20.51M
-4.42%20.15M
-16.15%77.42M
-21.05%17.32M
-6.16%21.15M
-12.92%17.87M
-22.89%21.08M
-24.84%92.33M
-31.74%21.94M
Research and development costs
45.54%35.03M
0.14%29.72M
-10.05%27.41M
-47.71%114.16M
-13.81%29.94M
-28.34%24.07M
-30.55%29.68M
-71.59%30.47M
-45.46%218.32M
-65.13%34.74M
Operating profit
-2.37%-34.3M
-7.17%-36.49M
6.93%-34.45M
43.71%-135.23M
25.02%-30.66M
10.59%-33.5M
27.24%-34.05M
67.84%-37.02M
46.15%-240.24M
63.79%-40.89M
Net non-operating interest income expense
-269.53%-2.58M
-91.96%-2.51M
36.67%-1.31M
71.42%-6.33M
43.17%-2.25M
85.74%-699K
78.70%-1.31M
70.98%-2.07M
50.37%-22.13M
49.14%-3.96M
Non-operating interest income
-34.04%3.44M
-19.50%3.9M
-2.65%4.22M
180.24%19.01M
42.41%4.62M
154.20%5.21M
342.15%4.85M
997.47%4.34M
148.37%6.78M
845.19%3.24M
Non-operating interest expense
1.86%6.02M
4.16%6.41M
-13.65%5.53M
-12.37%25.33M
-4.64%6.87M
-15.00%5.91M
-14.89%6.15M
-14.93%6.41M
-38.89%28.91M
-11.39%7.2M
Other net income (expense)
98.58%-166K
15.76%-13.33M
98.90%-1.07M
-31.27%-134.71M
21.36%-9.2M
30.51%-11.7M
85.08%-15.82M
-406.69%-98M
-214.83%-102.62M
53.13%-11.7M
Gain on sale of security
----
----
----
----
----
----
----
----
516.64%33.43M
--0
Special income (charges)
99.60%-46K
19.72%-13.29M
99.00%-975K
5.50%-128.46M
75.38%-2.85M
32.50%-11.36M
84.39%-16.55M
-6,523.32%-97.69M
---135.93M
---11.58M
-Less：Restructuring and merger&acquisition
-96.12%46K
50.35%4.96M
-87.80%975K
-79.14%15.33M
-62.81%2.85M
-92.41%1.19M
-93.23%3.3M
441.90%7.99M
--73.5M
--7.67M
-Less:Impairment of capital assets
--0
-37.16%8.33M
--0
70.05%111.83M
-117.96%-1.3M
747.75%10.17M
-76.88%13.26M
--89.7M
--65.76M
--7.24M
-Gain on sale of property,plant,equipment
----
----
----
-139.09%-1.3M
----
----
----
----
--3.33M
----
Other non- operating income (expenses)
64.18%-120K
-104.89%-36K
67.11%-99K
-5,285.34%-6.25M
---6.35M
---335K
--736K
---301K
99.53%-116K
----
Income before tax
19.28%-37.05M
-2.24%-52.32M
73.13%-36.84M
24.31%-276.26M
25.53%-42.11M
22.47%-45.9M
67.81%-51.17M
-51.86%-137.08M
30.25%-364.98M
61.18%-56.54M
Income tax
114.75%9K
197.87%46K
44.44%-35K
-106.22%-200K
-100.92%-29K
60.65%-61K
-147.00%-47K
-150.00%-63K
477.20%3.22M
78,700.00%3.14M
Net income
19.15%-37.06M
-2.43%-52.36M
73.14%-36.8M
25.03%-276.06M
29.50%-42.08M
22.37%-45.84M
67.86%-51.12M
-51.58%-137.02M
29.71%-368.2M
59.02%-59.69M
Net income continuous Operations
19.15%-37.06M
-2.43%-52.36M
73.14%-36.8M
25.03%-276.06M
29.50%-42.08M
22.37%-45.84M
67.86%-51.12M
-51.58%-137.02M
29.71%-368.2M
59.02%-59.69M
Minority interest income
Net income attributable to the parent company
19.15%-37.06M
-2.43%-52.36M
73.14%-36.8M
25.03%-276.06M
29.50%-42.08M
22.37%-45.84M
67.86%-51.12M
-51.58%-137.02M
29.71%-368.2M
59.02%-59.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.15%-37.06M
-2.43%-52.36M
73.14%-36.8M
25.03%-276.06M
29.50%-42.08M
22.37%-45.84M
67.86%-51.12M
-51.58%-137.02M
29.71%-368.2M
59.02%-59.69M
Basic earnings per share
25.00%-0.18
7.41%-0.25
73.97%-0.19
26.40%-1.45
31.25%-0.22
22.58%-0.24
68.24%-0.27
-48.98%-0.73
31.12%-1.97
59.49%-0.32
Diluted earnings per share
25.00%-0.18
7.41%-0.25
73.97%-0.19
26.40%-1.45
31.25%-0.22
22.58%-0.24
68.24%-0.27
-48.98%-0.73
31.12%-1.97
59.49%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -0.08%24.12M14.59%23.49M0.21%21.64M-2.10%90.12M8.45%23.89M2.20%24.14M-5.03%20.5M-13.00%21.59M-9.67%92.06M-11.94%22.02M
Operating revenue -0.08%24.12M14.59%23.49M0.21%21.64M-2.10%90.12M8.45%23.89M2.20%24.14M-5.03%20.5M-13.00%21.59M-9.67%92.06M-11.94%22.02M
Cost of revenue -64.32%4.44M39.26%9.74M20.88%8.53M56.08%33.77M16.85%7.28M150.02%12.43M36.74%6.99M32.83%7.06M-13.10%21.64M1.14%6.23M
Gross profit 68.10%19.69M1.81%13.75M-9.83%13.11M-19.97%56.35M5.14%16.6M-37.21%11.71M-18.00%13.51M-25.49%14.53M-8.56%70.42M-16.22%15.79M
Operating expense 19.40%53.99M5.64%50.23M-7.75%47.56M-38.33%191.58M-16.61%47.26M-19.43%45.22M-24.84%47.55M-61.70%51.55M-40.61%310.66M-56.98%56.68M
Selling and administrative expenses -10.36%18.96M14.78%20.51M-4.42%20.15M-16.15%77.42M-21.05%17.32M-6.16%21.15M-12.92%17.87M-22.89%21.08M-24.84%92.33M-31.74%21.94M
-General and administrative expense -10.36%18.96M14.78%20.51M-4.42%20.15M-16.15%77.42M-21.05%17.32M-6.16%21.15M-12.92%17.87M-22.89%21.08M-24.84%92.33M-31.74%21.94M
Research and development costs 45.54%35.03M0.14%29.72M-10.05%27.41M-47.71%114.16M-13.81%29.94M-28.34%24.07M-30.55%29.68M-71.59%30.47M-45.46%218.32M-65.13%34.74M
Operating profit -2.37%-34.3M-7.17%-36.49M6.93%-34.45M43.71%-135.23M25.02%-30.66M10.59%-33.5M27.24%-34.05M67.84%-37.02M46.15%-240.24M63.79%-40.89M
Net non-operating interest income expense -269.53%-2.58M-91.96%-2.51M36.67%-1.31M71.42%-6.33M43.17%-2.25M85.74%-699K78.70%-1.31M70.98%-2.07M50.37%-22.13M49.14%-3.96M
Non-operating interest income -34.04%3.44M-19.50%3.9M-2.65%4.22M180.24%19.01M42.41%4.62M154.20%5.21M342.15%4.85M997.47%4.34M148.37%6.78M845.19%3.24M
Non-operating interest expense 1.86%6.02M4.16%6.41M-13.65%5.53M-12.37%25.33M-4.64%6.87M-15.00%5.91M-14.89%6.15M-14.93%6.41M-38.89%28.91M-11.39%7.2M
Other net income (expense) 98.58%-166K15.76%-13.33M98.90%-1.07M-31.27%-134.71M21.36%-9.2M30.51%-11.7M85.08%-15.82M-406.69%-98M-214.83%-102.62M53.13%-11.7M
Gain on sale of security --------------------------------516.64%33.43M--0
Special income (charges) 99.60%-46K19.72%-13.29M99.00%-975K5.50%-128.46M75.38%-2.85M32.50%-11.36M84.39%-16.55M-6,523.32%-97.69M---135.93M---11.58M
-Less：Restructuring and merger&acquisition -96.12%46K50.35%4.96M-87.80%975K-79.14%15.33M-62.81%2.85M-92.41%1.19M-93.23%3.3M441.90%7.99M--73.5M--7.67M
-Less:Impairment of capital assets --0-37.16%8.33M--070.05%111.83M-117.96%-1.3M747.75%10.17M-76.88%13.26M--89.7M--65.76M--7.24M
-Gain on sale of property,plant,equipment -------------139.09%-1.3M------------------3.33M----
Other non- operating income (expenses) 64.18%-120K-104.89%-36K67.11%-99K-5,285.34%-6.25M---6.35M---335K--736K---301K99.53%-116K----
Income before tax 19.28%-37.05M-2.24%-52.32M73.13%-36.84M24.31%-276.26M25.53%-42.11M22.47%-45.9M67.81%-51.17M-51.86%-137.08M30.25%-364.98M61.18%-56.54M
Income tax 114.75%9K197.87%46K44.44%-35K-106.22%-200K-100.92%-29K60.65%-61K-147.00%-47K-150.00%-63K477.20%3.22M78,700.00%3.14M
Net income 19.15%-37.06M-2.43%-52.36M73.14%-36.8M25.03%-276.06M29.50%-42.08M22.37%-45.84M67.86%-51.12M-51.58%-137.02M29.71%-368.2M59.02%-59.69M
Net income continuous Operations 19.15%-37.06M-2.43%-52.36M73.14%-36.8M25.03%-276.06M29.50%-42.08M22.37%-45.84M67.86%-51.12M-51.58%-137.02M29.71%-368.2M59.02%-59.69M
Minority interest income
Net income attributable to the parent company 19.15%-37.06M-2.43%-52.36M73.14%-36.8M25.03%-276.06M29.50%-42.08M22.37%-45.84M67.86%-51.12M-51.58%-137.02M29.71%-368.2M59.02%-59.69M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.15%-37.06M-2.43%-52.36M73.14%-36.8M25.03%-276.06M29.50%-42.08M22.37%-45.84M67.86%-51.12M-51.58%-137.02M29.71%-368.2M59.02%-59.69M
Basic earnings per share 25.00%-0.187.41%-0.2573.97%-0.1926.40%-1.4531.25%-0.2222.58%-0.2468.24%-0.27-48.98%-0.7331.12%-1.9759.49%-0.32
Diluted earnings per share 25.00%-0.187.41%-0.2573.97%-0.1926.40%-1.4531.25%-0.2222.58%-0.2468.24%-0.27-48.98%-0.7331.12%-1.9759.49%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List